Free Trial

Neville Rodie & Shaw Inc. Raises Stock Position in Salesforce Inc. $CRM

Salesforce logo with Computer and Technology background

Key Points

  • Neville Rodie & Shaw Inc. increased its stake in Salesforce Inc. by 4.6%, acquiring an additional 2,644 shares, bringing their total holdings to 59,970 shares valued at approximately $16.35 million.
  • Salesforce reported a quarterly EPS of $2.91, exceeding analyst expectations, with revenue reaching $10.24 billion, reflecting a year-over-year growth of 9.8%.
  • The company declared a quarterly dividend of $0.416, with an annualized yield of 0.7%, scheduled to be paid on October 9th.
  • Five stocks to consider instead of Salesforce.

Neville Rodie & Shaw Inc. lifted its stake in shares of Salesforce Inc. (NYSE:CRM - Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,970 shares of the CRM provider's stock after purchasing an additional 2,644 shares during the period. Salesforce accounts for 1.2% of Neville Rodie & Shaw Inc.'s investment portfolio, making the stock its 22nd biggest holding. Neville Rodie & Shaw Inc.'s holdings in Salesforce were worth $16,353,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of CRM. Nuveen LLC purchased a new stake in shares of Salesforce during the 1st quarter worth approximately $2,039,196,000. GAMMA Investing LLC increased its stake in shares of Salesforce by 30,456.9% during the 1st quarter. GAMMA Investing LLC now owns 3,801,588 shares of the CRM provider's stock worth $1,020,194,000 after purchasing an additional 3,789,147 shares during the last quarter. Longview Partners Guernsey LTD purchased a new stake in shares of Salesforce during the 1st quarter worth approximately $467,944,000. Pacer Advisors Inc. increased its stake in shares of Salesforce by 1,744.0% during the 1st quarter. Pacer Advisors Inc. now owns 1,820,262 shares of the CRM provider's stock worth $488,486,000 after purchasing an additional 1,721,550 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Salesforce by 1.6% in the first quarter. Vanguard Group Inc. now owns 87,913,628 shares of the CRM provider's stock valued at $23,592,501,000 after purchasing an additional 1,383,942 shares during the period. Hedge funds and other institutional investors own 80.43% of the company's stock.

Insiders Place Their Bets

In related news, CEO Marc Benioff sold 2,250 shares of Salesforce stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $257.02, for a total value of $578,295.00. Following the transaction, the chief executive officer owned 11,911,571 shares in the company, valued at $3,061,511,978.42. This trade represents a 0.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David Blair Kirk bought 3,400 shares of the firm's stock in a transaction that occurred on Tuesday, September 9th. The stock was acquired at an average price of $254.66 per share, for a total transaction of $865,844.00. Following the transaction, the director owned 3,824 shares in the company, valued at $973,819.84. This trade represents a 801.89% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders sold 72,827 shares of company stock worth $18,554,576. 3.00% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CRM has been the subject of a number of recent research reports. Roth Capital reiterated a "buy" rating and issued a $395.00 price objective on shares of Salesforce in a research note on Thursday, September 4th. Stephens reduced their price target on Salesforce from $311.00 to $309.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Barclays cut their target price on Salesforce from $347.00 to $316.00 and set an "overweight" rating for the company in a research note on Monday, August 18th. BMO Capital Markets reduced their target price on Salesforce from $335.00 to $280.00 and set an "outperform" rating for the company in a report on Thursday, September 4th. Finally, KeyCorp lowered their price target on shares of Salesforce from $440.00 to $400.00 and set an "overweight" rating on the stock in a report on Thursday, September 4th. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $332.58.

View Our Latest Stock Report on CRM

Salesforce Trading Down 0.2%

Shares of Salesforce stock traded down $0.43 during trading on Monday, reaching $242.33. The company's stock had a trading volume of 7,191,474 shares, compared to its average volume of 7,557,481. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.14. Salesforce Inc. has a 52-week low of $226.48 and a 52-week high of $369.00. The firm's 50-day moving average is $253.21 and its two-hundred day moving average is $264.29. The company has a market cap of $230.70 billion, a price-to-earnings ratio of 35.22, a PEG ratio of 2.21 and a beta of 1.22.

Salesforce (NYSE:CRM - Get Free Report) last issued its earnings results on Wednesday, September 3rd. The CRM provider reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.78 by $0.13. The company had revenue of $10.24 billion for the quarter, compared to analysts' expectations of $10.14 billion. Salesforce had a net margin of 16.87% and a return on equity of 13.27%. The firm's revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.56 EPS. Salesforce has set its FY 2026 guidance at 11.330-11.370 EPS. Q3 2026 guidance at 2.840-2.860 EPS. On average, sell-side analysts anticipate that Salesforce Inc. will post 7.46 earnings per share for the current year.

Salesforce Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 9th. Investors of record on Wednesday, September 17th will be given a $0.416 dividend. This represents a $1.66 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 17th. Salesforce's dividend payout ratio (DPR) is presently 24.13%.

Salesforce Profile

(Free Report)

Salesforce, Inc provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. The company's service includes sales to store data, monitor leads and progress, forecast opportunities, gain insights through analytics and artificial intelligence, and deliver quotes, contracts, and invoices; and service that enables companies to deliver trusted and highly personalized customer support at scale.

Read More

Institutional Ownership by Quarter for Salesforce (NYSE:CRM)

Should You Invest $1,000 in Salesforce Right Now?

Before you consider Salesforce, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Salesforce wasn't on the list.

While Salesforce currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month
He Said Sell Oracle. Here’s What Happened Next.

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines